What do TCR² Therapeutics and Adaptimmune have in common? They’re both T-cell-focused drug developers that have been shedding staff in recent weeks to stay afloat. Now, they’re combining into one ...
To accelerate biotechnology innovations, such as the development of lifesaving drug therapies, scientists strive to develop faster, more quantitative and more widely available ways to observe ...